[go: up one dir, main page]

GB1320298A - Peptides - Google Patents

Peptides

Info

Publication number
GB1320298A
GB1320298A GB5346372A GB5346372A GB1320298A GB 1320298 A GB1320298 A GB 1320298A GB 5346372 A GB5346372 A GB 5346372A GB 5346372 A GB5346372 A GB 5346372A GB 1320298 A GB1320298 A GB 1320298A
Authority
GB
United Kingdom
Prior art keywords
thr
leu
ser
glu
june
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5346372A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH995769A external-priority patent/CH515216A/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB1320298A publication Critical patent/GB1320298A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1320298 Peptide SANDOZ Ltd 22 May 1970 [3 June 1969 20 June 1969 (4) 23 June 1969 (3) 26 June 1969 30 June 1969 9 Sept 1969] 53463/72 Divided out of 1314051 Heading C2C The novel peptide compound I H - cys - ser - asn - leu - ser - thr - cys - val - leugly - lys - leu - ser - glu - glu - leu - his - lys - leuglu - thr - tyr - pro - arg - thr - asn - thr - glyser-gly-thr-pro-NH 2 is prepared by methods known per se. In the example it is prepared from the compound II BOC - cys - ser - asn - leu - ser - thr - cys - valleu - gly - lys - (BOC) - leu - ser - glu - glu(OTB)- leu - his - lys(BOC) - leu - glu - thr - tyr - proarg-thr-asn-thr-gly-ser-gly-thr-pro-NH 2 by treatment with CF 3 COOH. The starting material and its preparation are described in Specification 1,314,051. Pharmaceutical compositions comprise the peptide I and a suitable carrier and are used in lowering the calcium content of blood plasma.
GB5346372A 1969-06-03 1970-05-22 Peptides Expired GB1320298A (en)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
CH840569 1969-06-03
CH945369 1969-06-20
CH945169 1969-06-20
CH945269 1969-06-20
CH946169 1969-06-20
CH956169 1969-06-23
CH955969 1969-06-23
CH956069 1969-06-23
CH979269 1969-06-26
CH995769A CH515216A (en) 1969-06-30 1969-06-30 Synthetic polypeptides - salmon calcitonin derivs. with pharmacodynamic properties
CH1361269 1969-09-09
GB2477970 1970-05-22

Publications (1)

Publication Number Publication Date
GB1320298A true GB1320298A (en) 1973-06-13

Family

ID=27582893

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5346372A Expired GB1320298A (en) 1969-06-03 1970-05-22 Peptides

Country Status (1)

Country Link
GB (1) GB1320298A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5148660A (en) * 1974-08-12 1976-04-26 Armour Pharma Sake karushitoninno gosei
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5148660A (en) * 1974-08-12 1976-04-26 Armour Pharma Sake karushitoninno gosei
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity

Similar Documents

Publication Publication Date Title
ES8203385A1 (en) N-(vinblastinoyl-23) derivatives of amino acids and peptides and their preparation.
IL45160A (en) Peptides which inhibit release of growth hormone, their prduction and pharmaceutical compositions containing them
IL75637A0 (en) Thymopentin analogs and pharmaceutical compositions containing them
ATE10364T1 (en) RETRO-INVERSO ANALOGUES OF C-TERMINAL PENTAAND HEXAPEPTIDES OF COMPOUND P.
GB1320298A (en) Peptides
GB1294771A (en) Thyrocalcitonin derivative
GB1362743A (en) Nonapeptides and a process for the manufacture thereof
GB1239960A (en) Octapeptide intermediates
GB1536878A (en) Octapeptide
GB1140873A (en) Polypeptides
GB1483650A (en) Pharmaceutical preparations based on mesterolone
GB1435685A (en) Hydroxyl-subst
ES8204713A1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it.
GB1210551A (en) New peptides having an acth-activity and process for their manufacture
GB1329869A (en) Tetracycline derivatives
GB1314051A (en) Polypeptides and their derivatives
GB1317028A (en) Derivatives of secretin
GB1298318A (en) Corticotropin peptides
GB1412094A (en) Pharmaceutical compositions containing p-chlorohippuric acid or salts thereof
GB1279915A (en) 0-aryl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine-2-ones and a process for their preparation
JPS5272885A (en) Preparation of peptide
GB1273873A (en) Corticotropically highly active octadecapeptides
GB1357683A (en) Glucagon and process of producing
GB1435285A (en) Process for preparing pyroglutamyl-histidyl-prolinamide
GB1425512A (en) N-n-n-n-n-5-oxo-l-prolyl-l-histidyl-l-triptophyl-l-seryl-l- tyrosyl- glycerine hydrazide trifluoroacetate

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years